Articles

Poll

Podcasts

Slideshows

Videos

Dermatology

The HCPLive dermatology page is a resource for medical news and expert insights on skin disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for dermatologic conditions, and more.

Catch up on some of the most notable headlines in psoriasis news coverage from 2025 with our Year in Review.

Psoriasis in 2025: Year in Review

In this analysis, investigators assessed the effects of any weight-loss intervention, behavioural or pharmacological, on the severity of psoriasis as well as quality-of-life outcomes.

Weight-Loss Interventions Improve Psoriasis Severity, Quality of Life

Topical steroid withdrawal remains a controversial topic in the dermatology field, given the lack of necessary data. 

 Topical Steroid Withdrawal: Inside the Controversy Over TSW in Dermatology

The highly selective oral TYK2 inhibitor met coprimary endpoints for sPGA 0/1 and PASI 75 at week 16 versus placebo in the phase 3 Latitude studies.

Once-Daily Oral Zasocitinib Delivers Strong Phase 3 Efficacy in Plaque Psoriasis

Investigators highlighted patterns of addictive behavior among those with chronic skin diseases in European tertiary dermatology centers.

Addictive Behaviors Linked with Chronic Skin Diseases Such as HS, Psoriasis

Vanda Pharmaceuticals submitted a BLA to the FDA for imsidolimab, a novel IgG4 IL-36 receptor antagonist, to treat generalized pustular psoriasis (GPP).

Imsidolimab’s Biologics License Application for Treatment of GPP Submitted to FDA 

The phase 3 DISCREET study explored the safety and efficacy of apremilast in treating patients with moderate to severe genital psoriasis over 32 weeks.

Apremilast Effective Treatment for Moderate to Severe Genital Psoriasis at 32 Weeks

From diagnosis, investigators sought to explore psoriasis characteristics, patient demographics, patterns of treatment, and disease progression.

Mild to Moderate Psoriasis Linked with Indicators of Suboptimal Treatment, Disease Control

Explore the evolving role of AI in dermatology, balancing its benefits with concerns over accuracy, bias, and the human touch in patient care.

AI in Dermatology: Discussing Downsides to the Adoption of Artificial Intelligence 

This analysis suggests a potential causal association between psoriasis and depression, highlighting the need for mental health screening in patients with psoriasis.

Potential Causal Relationship Identified Between Depression, Psoriasis

The HCPLive plaque psoriasis page is a resource for medical news and expert insights on psoriasis. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for psoriatic disease, and more.